Results 251 to 260 of about 106,428 (294)

Quantitative proteomic analysis of the protective effect exerted by alliin on ox-LDL-injured HUVECs. [PDF]

Sci Rep
Tang YY, Lv.
europepmc   +1 more source

A Multimarker Model for Prostate Cancer Risk Assessment: Improving Diagnostic Accuracy Beyond PSA

The Prostate, EarlyView.
ABSTRACT Objective This study aimed to evaluate the association between biochemical markers and prostate cancer (PCa) risk by analyzing patients with benign prostatic hyperplasia (BPH) and PCa. Additionally, the study sought to assess the diagnostic accuracy of a multimarker model compared to prostate‐specific antigen (PSA) alone.
Penglu Yang, Bin Yang
wiley   +1 more source

Association of Cumulative Exposure to Triglyceride and Remnant Cholesterol With the Risk of Cardiovascular Disease in Hypertensive Patients With Target LDL-C. [PDF]

J Clin Hypertens (Greenwich)
Guo S, Wang C, Hu T, Lan L, Ge Z, Huang J, Chen S, Wu S, Xue H.   +8 more
europepmc   +1 more source

Modeling of Disease Progression of Type 2 Diabetes Using Real‐World Data: Quantifying Competing Risks of Morbidity and Mortality

CPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 3, Page 606-615, March 2025.
ABSTRACT Type 2 diabetes (T2D) is a progressive metabolic disorder that could be an underlying cause of long‐term complications that increase mortality. The assessment of the probability of such events could be essential for mortality risk management. This work aimed to establish a framework for risk predictions of macrovascular complications (MVC) and
Hanna Kunina, Stefan Franzén, Maria C. Kjellsson   +2 more
wiley   +1 more source

Effects of Blueberry Consumption on Fecal Microbiome Composition and Circulating Metabolites, Lipids, and Lipoproteins in a Randomized Controlled Trial of Older Adults with Overweight or Obesity: The BEACTIVE Trial. [PDF]

Nutrients
Porter Starr KN, Connelly MA, Wallis J, North R, Zhang Q, Song K, González-Delgado JM, Brochu HN, Icenhour CR, Iyer LK, Miller MG, Huffman KM, Kraus WE, Bales CW.   +13 more
europepmc   +1 more source

Population Pharmacokinetics and Exposure‐Response Modeling for Evinacumab in Children, Adolescents, and Adults With Homozygous Familial Hypercholesterolemia

CPT: Pharmacometrics &Systems Pharmacology, EarlyView.
ABSTRACT Evinacumab, an angiopoietin‐like 3 (ANGPTL3) inhibitor, significantly reduces low‐density lipoprotein cholesterol (LDL‐C), independent of low‐density lipoprotein receptor, in patients with homozygous familial hypercholesterolemia (HoFH). A population pharmacokinetic (PK)/pharmacodynamic (PD) model was previously developed to characterize ...
Sébastien Bihorel, Robert Dingman, Jeanne Mendell, Yuhuan Wang, Poulabi Banerjee, Robert Pordy, John D. Davis, A. Thomas DiCioccio, Lutz Harnisch   +8 more
wiley   +1 more source

The potential of serum and salivary interleukin-1β and matrix metalloproteinase-8 as determinants of periodontitis grading. [PDF]

BMC Oral Health
Uzar E, Gurbuz N, Akpınar Z, Ergin M, Koşkan Ö, Ay ZY.   +5 more
europepmc   +1 more source

Stationary screen time, blood lipids, and atherosclerotic cardiovascular disease incidence. [PDF]

BMC Cardiovasc Disord
Liu Y, Xu L, Liu P, Liao X, Liao J.
europepmc   +1 more source

Cardiometabolic Risk Assessment in Transgender Individuals-Differential Effect of Sex Hormones and Sex Chromosomes.

J Clin Endocrinol Metab
Lei Y, Wiik A, Connelly MA, Lindberg L, Andersson DP, Arver S, Gustafsson T, Tietge UJF.   +7 more
europepmc   +1 more source

Targeting Mitochondrial Dysfunction to Prevent Endothelial Dysfunction and Atherosclerosis in Diabetes: Focus on the Novel Uncoupler BAM15. [PDF]

Int J Mol Sci
Jang WB, Rethineswaran VK, Kwon SM.
europepmc   +1 more source